CRH PLC (CRH.L)

CRH.L on London Stock Exchange

1,386.00
9:52am EDT
Price Change (% chg)

4.00null (+0.29%)
Prev Close
1,382.00null
Open
1,402.00null
Day's High
1,407.00null
Day's Low
1,386.00null
Volume
1,012,621
Avg. Vol
2,930,838
52-wk High
1,811.00null
52-wk Low
1,220.00null

CRH.L

Chart for CRH.L

About

CRH plc is a diversified building materials company, which manufactures and distributes building material products from the fundamentals of heavy materials and elements to construct the frame, through exterior products that complete the building envelope, to distribution channels, which service construction fit-out and renewal.... (more)

Overall

No Ratios Available.

Financials

  CRH.L Industry Sector
P/E (TTM): -- 16.97 23.31
EPS (TTM): -- -- --
ROI: -- 22.41 15.37
ROE: -- 25.69 17.69
Search Stocks

Two industry groups eye Lafarge-Holcim assets - sources

* CRH teams up with Cemex to explore bid for assets - sources

07 Oct 2014

CRH, PE firms mull bids for entire Lafarge-Holcim portfolio: sources

LONDON - Irish cement maker CRH is exploring a bid for all the assets rivals Lafarge and Holcim must sell to steer their mega-merger past competition watchdogs, two sources familiar with the matter told Reuters.

18 Sep 2014

CRH, PE firms mull bids for entire Lafarge-Holcim portfolio -sources

* CRH exploring bid for all of assets put for sale -sources

18 Sep 2014

UK's FTSE retreats as Ukraine tension grows

* Steady German inflation leaves open risk of euro zone dip

28 Aug 2014

UK's FTSE retreats as Ukraine tension grows

* Steady German inflation leaves open risk of euro zone dip

28 Aug 2014

Healthcare stocks lift UK's FTSE 100

* FTSE 100 up 0.3 pct, near 3-week high * AstraZeneca up on speculation over new Pfizer bid * Building supplies group CRH boosted by analyst upgrade * Miners lag after weak Chinese data By Tricia Wright and Sudip Kar-Gupta LONDON, Aug 21 - Britain's top equity index rose on Thursday on gains in healthcare stocks, led by AstraZeneca on speculation rejected U.S. suitor Pfizer might make another bid. AstraZeneca rose 3 percent while domestic rival GlaxoSmithKline

21 Aug 2014

CRH returns to after-tax profit in first half

DUBLIN, Aug 19 - Irish building supplies group CRH said on Tuesday it returned to profit after tax in the first half on a strong performance in Europe, adding that despite concerns about Ukraine it was on track to hit earnings targets for the year.

19 Aug 2014

CRH's Swiss businesses face $130 million in fines from competition watchdog

DUBLIN - Swiss subsidiaries of CRH face fines of up to 119 million Swiss francs ($133 million) over alleged infringements of competition law, the Irish building materials company said on Friday.

30 May 2014

CRH's Swiss businesses face $130 mln in fines from competition watchdog

DUBLIN, May 30 - Swiss subsidiaries of CRH face fines of up to 119 million Swiss francs ($133 million) over alleged infringements of competition law, the Irish building materials company said on Friday.

30 May 2014

UPDATE 1-Ireland's CRH sees little impact from Holcim, Lafarge merger

* Expects earnings to rise, some sign of European pick up (Adds CEO quotes on Holcim, Lafarge merger)

07 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$92.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks